Awaiting development: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Type

Guidance programme

Showing 1 to 2 of 2

TitleType
Budesonide oral suspension for inducing and maintaining remission of eosinophilic oesophagitis in people 2 to 17 years [ID6761]Technology appraisal guidance
Budesonide orodispersible tablet for maintaining remission of eosinophilic oesophagitis in people 18 years and over [ID6486]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All